Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

cNeuro cDAT

K-Number: K233908 · 2024-07-01

ApplicantCombinostics OY
Decision Date2024-07-01
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

cNeuro cDAT is a medical device manufactured by Combinostics OY. It received FDA 510(k) clearance on 2024-07-01 under approval number K233908. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the cNeuro cDAT?

cNeuro cDAT is a medical device that received FDA 510(k) clearance on 2024-07-01. It is manufactured by Combinostics OY. The 510(k) number is K233908.

When was cNeuro cDAT approved by the FDA?

cNeuro cDAT received FDA 510(k) clearance on 2024-07-01, under approval number K233908.

What company makes cNeuro cDAT?

cNeuro cDAT is manufactured by Combinostics OY.

What is the FDA product code for cNeuro cDAT?

The FDA product code for cNeuro cDAT is LLZ.

Other Devices by Combinostics OY

K171328cNeuro cMRI K231576cNeuro cPET

Related Devices (Code: LLZ)

K161959ClearView cCADClearview Diagnostics, Inc. K163539Ez3D-i / E3Ewoosoft Co., Ltd. K162955Multi-Modality Tumor Tracking (MMTT) applicationPhilips Medical Systems Nederland B.V. K160852ZiaZetta Medical Technologies, LLC K162376CAAS MR 4D FlowPie Medical Imaging BV K161322CT CoPilotZepmed, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑